COHEN RON 4
4 · ACORDA THERAPEUTICS INC · Filed Mar 21, 2022
Insider Transaction Report
Form 4
COHEN RON
President and CEO
Transactions
- Sale
Common Stock
2022-03-17$1.70/sh−2,289$3,895→ 129,601 total
Footnotes (2)
- [F1]These sales are primarily intended to cover the tax liability resulting from the settlement of vested restricted stock units.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.70 to $1.74 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.